Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Recruiting
N/A
Interventional Study
Cardiovascular Diseases
Acute Coronary Syndrome
Atherosclerosis
Hypercholesterolemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 2,000 (estimated)
- Sponsor
- Stephen Nicholls · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study. Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18 years of age
* Admission for Type I myocardial infarction
Exclusion Criteria:
* LDL \<1.4mmol/L at baseline
* Unable to provide contact details of primary care physician/general practitioner
* Unable to provide written informed consent.
* Unlikely to survive \>12 months
Contacts